SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-22-010970
Filing Date
2022-03-08
Accepted
2022-03-07 18:02:12
Documents
14
Period of Report
2021-01-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea156396-8ka1_biotechacq.htm   iXBRL 8-K/A 45824
2 AUDITED BALANCE SHEET AS OF JANUARY 28, 2021 (RESTATED) ea156396ex99-1_biotechacq.htm EX-99.1 116668
  Complete submission text file 0001213900-22-010970.txt   424601

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE biotu-20210128.xsd EX-101.SCH 4224
4 XBRL DEFINITION FILE biotu-20210128_def.xml EX-101.DEF 27600
5 XBRL LABEL FILE biotu-20210128_lab.xml EX-101.LAB 38171
6 XBRL PRESENTATION FILE biotu-20210128_pre.xml EX-101.PRE 26218
8 EXTRACTED XBRL INSTANCE DOCUMENT ea156396-8ka1_biotechacq_htm.xml XML 7387
Mailing Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001
Business Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001 8586920539
Biotech Acquisition Co (Filer) CIK: 0001825413 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39935 | Film No.: 22719606
SIC: 2834 Pharmaceutical Preparations